Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Nora Ranjitkar Manandhar"'
Publikováno v:
Journal of Patan Academy of Health Sciences. 5:4-11
DOI: https://doi.org/10.3126/jpahs.v5i2.23982 Introductions:Patients with chronic kidney disease have a high burden of somatic symptoms which may be due to depression. This study analyses occurrence of depression in patients with chronic kidney disea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4150ca18dc48d30d31cec14a41b09b43
https://doi.org/10.3126/jpahs.v5i2.23982
https://doi.org/10.3126/jpahs.v5i2.23982
Publikováno v:
Journal of Patan Academy of Health Sciences. 5:47-56
Introductions : Dasatinib is indicated as a first line, second line and third line tyrosine kinase inhibitor (TKI) in chronic myeloid leukemia (CML). In our center it is used as a second line or third line therapy in BCR-ABL gene positive CML. Method
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bccef478bce279bacfae763a09295142
https://doi.org/10.3126/jpahs.v5i1.24042
https://doi.org/10.3126/jpahs.v5i1.24042
Publikováno v:
Journal of Patan Academy of Health Sciences. 5:3-9
Introductions : Hepatitis C virus (HCV) infection is common in the patients undergoing hemodialysis (HD). The quality of life and survival of patients with hepatitis C infected end-stage renal disease is less than that of the noninfected ones. This s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::899054f41f9a8c022af8131d6dac2b20
https://doi.org/10.3126/jpahs.v5i1.24035
https://doi.org/10.3126/jpahs.v5i1.24035